The Global Health Body Sounds Concern Over Severe Shortage of Weight-Loss Injections

Fewer than one in 10 patients who could benefit from obesity jabs like Wegovy can access them, states the global health agency as it releases its inaugural advice on the medications.

With more than one billion people worldwide now obese, it is urging increased and just access to these injectable treatments.

Based on projections, over two billion could be obese by 2030 unless action is taken.

"The new guidelines affirms that obesity is a chronic disease that can be addressed with thorough and continuous care," stated the agency's head Tedros Adhanom Ghebreyesus.

Substantial prices, limited production capacity, and supply-chain constraints are significant hurdles to widespread availability to the jabs that can assist patients in reducing significant body mass, says the body.

Skinny Jab Shortage

Despite the current most optimistic scenario, the manufacturing of these medications might only reach approximately 100 million people – under 10% of those who need them, per the health organization.

The recommendation calls on nations and manufacturers to widen access, via strategies like licensing agreements.

The intellectual property rights on the active ingredient – the primary ingredient of a leading brand – is set to lapse in a number of countries in 2026.

The Way Obesity Drugs Operate

The injections replicate a body's own hormone to delay gastric emptying, suppress the appetite and increase the sense of being full so users consume fewer calories.

Patients commonly begin shedding pounds in the initial weeks of beginning the regular doses.

Evidence points to people may regain a significant portion after a year of halting the drug, because their typical food cravings come back.

To be carrying excess weight raises your risk for developing medical conditions, like diabetes, cardiovascular issues, stroke, and some malignancies.

Obesity impacts individuals in countries worldwide and was linked to millions of deaths worldwide in 2024, as per the health agency.